Literature DB >> 15654603

High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes.

A Imagawa1, T Hanafusa, H Makino, J-I Miyagawa, P Juto.   

Abstract

AIMS/HYPOTHESIS: We have recently proposed that fulminant type-1 diabetes is a novel subtype of type-1 diabetes with abrupt onset of insulin-deficient hyperglycaemia without islet-related autoantibodies. The pathogenesis is still unknown, but flu-like symptoms are frequently observed before the onset of disease of this subtype. Enterovirus infection is a candidate environmental factor causing type-1 diabetes. The aim of this study was to determine whether enterovirus infection contributes to the development of fulminant type-1 diabetes.
METHODS: We investigated 19 patients with recent-onset fulminant type-1 diabetes, 18 patients with recent-onset typical type-1A diabetes, and 19 healthy controls. IgM, IgG, and IgA subclasses of antibodies to enterovirus were determined by ELISA.
RESULTS: IgA antibody titres to enterovirus were significantly higher in fulminant type-1 diabetes than in typical type-1A diabetes (p=0.033) and controls (p=0.0003). IgM antibodies to enterovirus were not detected in any subject. IgG titres were lower in autoimmune diabetes than fulminant type and controls (p=0.014 and 0.019, respectively). CONCLUSIONS/
INTERPRETATION: High titres of enterovirus IgA antibodies in serum suggest recurrent enterovirus infection in fulminant type-1 diabetic patients, indicating higher susceptibility to enteroviral infections among them. Such infections might have pathogenetic importance in the triggering of fulminant type-1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15654603     DOI: 10.1007/s00125-004-1624-z

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  10 in total

1.  A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group.

Authors:  A Imagawa; T Hanafusa; J Miyagawa; Y Matsuzawa
Journal:  N Engl J Med       Date:  2000-02-03       Impact factor: 91.245

2.  Isolation of a virus from the pancreas of a child with diabetic ketoacidosis.

Authors:  J W Yoon; M Austin; T Onodera; A L Notkins
Journal:  N Engl J Med       Date:  1979-05-24       Impact factor: 91.245

Review 3.  The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals.

Authors:  H S Jun; J W Yoon
Journal:  Diabetologia       Date:  2001-03       Impact factor: 10.122

4.  Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus.

Authors:  A Imagawa; T Hanafusa; Y Uchigata; A Kanatsuka; E Kawasaki; T Kobayashi; A Shimada; I Shimizu; T Maruyama; H Makino
Journal:  Diabetologia       Date:  2005-02-02       Impact factor: 10.122

5.  Acute onset of type I diabetes mellitus after severe echovirus 9 infection: putative pathogenic pathways.

Authors:  G R Vreugdenhil; N C Schloot; A Hoorens; C Rongen; D G Pipeleers; W J Melchers; B O Roep; J M Galama
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

Review 6.  The role of enteroviral infections in the development of IDDM: limitations of current approaches.

Authors:  P M Graves; J M Norris; M A Pallansch; I C Gerling; M Rewers
Journal:  Diabetes       Date:  1997-02       Impact factor: 9.461

7.  Fulminant type 1 diabetes: a nationwide survey in Japan.

Authors:  Akihisa Imagawa; Toshiaki Hanafusa; Yasuko Uchigata; Azuma Kanatsuka; Eiji Kawasaki; Tetsuro Kobayashi; Akira Shimada; Ikki Shimizu; Tetsuya Toyoda; Taro Maruyama; Hideichi Makino
Journal:  Diabetes Care       Date:  2003-08       Impact factor: 19.112

8.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

9.  Serum IgA, IgG, and IgM responses to different enteroviruses as measured by a coxsackie B5-based indirect ELISA.

Authors:  J Boman; B Nilsson; P Juto
Journal:  J Med Virol       Date:  1992-09       Impact factor: 2.327

10.  Association of fulminant type 1 diabetes with pregnancy.

Authors:  I Shimizu; H Makino; H Osawa; E Kounoue; A Imagawa; T Hanafusa; E Kawasaki; Y Fujii
Journal:  Diabetes Res Clin Pract       Date:  2003-10       Impact factor: 5.602

  10 in total
  18 in total

Review 1.  Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host.

Authors:  Didier Hober; Pierre Sauter
Journal:  Nat Rev Endocrinol       Date:  2010-03-30       Impact factor: 43.330

2.  Pathogenesis of fulminant type 1 diabetes.

Authors:  Akihisa Imagawa; Toshiaki Hanafusa
Journal:  Rev Diabet Stud       Date:  2007-02-10

Review 3.  Type 1 diabetes in Japan.

Authors:  E Kawasaki; N Matsuura; K Eguchi
Journal:  Diabetologia       Date:  2006-03-28       Impact factor: 10.122

Review 4.  Death waits for no man--does it wait for a virus? How enteroviruses induce and control cell death.

Authors:  Katharine G Harris; Carolyn B Coyne
Journal:  Cytokine Growth Factor Rev       Date:  2014-08-15       Impact factor: 7.638

5.  Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset.

Authors:  Y Kawabata; H Ikegami; T Awata; A Imagawa; T Maruyama; E Kawasaki; S Tanaka; A Shimada; H Osawa; T Kobayashi; T Hanafusa; K Tokunaga; H Makino
Journal:  Diabetologia       Date:  2009-10-08       Impact factor: 10.122

Review 6.  The pancreas in human type 1 diabetes.

Authors:  Patrick A Rowe; Martha L Campbell-Thompson; Desmond A Schatz; Mark A Atkinson
Journal:  Semin Immunopathol       Date:  2010-05-22       Impact factor: 9.623

7.  Class II HLA genotype in fulminant type 1 diabetes: A nationwide survey with reference to glutamic acid decarboxylase antibodies.

Authors:  Chiharu Tsutsumi; Akihisa Imagawa; Hiroshi Ikegami; Hideichi Makino; Tetsuro Kobayashi; Toshiaki Hanafusa
Journal:  J Diabetes Investig       Date:  2012-02-20       Impact factor: 4.232

8.  Fulminant type 1 diabetes mellitus associated with a reactivation of Epstein-Barr virus that developed in the course of chemotherapy of multiple myeloma.

Authors:  Atsushi Fujiya; Hiroshi Ochiai; Toshihiro Mizukoshi; Atsushi Kiyota; Taiga Shibata; Atsushi Suzuki; Norimi Ohashi; Hiroshi Sobajima
Journal:  J Diabetes Investig       Date:  2010-12-03       Impact factor: 4.232

9.  An Unusual Case of Fulminant Type 1 Diabetes during the Second Trimester of Pregnancy.

Authors:  Tomohiro Okuda; Sadao Yamashita; Yoshio Ogino; Hisashi Kataoka; Jo Kitawaki
Journal:  Case Rep Obstet Gynecol       Date:  2014-08-11

Review 10.  Mechanisms of Beta Cell Dysfunction Associated With Viral Infection.

Authors:  Antje Petzold; Michele Solimena; Klaus-Peter Knoch
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.